Nachrichten zur Iovance Biotherapeutics Aktie

Is Iovance Biotherapeutics Stock a Buy?

The biotech is making important breakthroughs, but is that enough?…

Iovance Biotherapeutics: Moving To The Next Phase

…

3 Reasons to Buy Iovance Biotherapeutics Stock Like Theres No Tomorrow @themotleyfool #stocks $IOVA

This biotechs growth story is going to start moving faster, and soon.…

3 Reasons to Buy Iovance Biotherapeutics Stock Like Theres No Tomorrow

This biotechs growth story is going to start moving faster, and soon.…

3 Things You Need to Know if You Buy Iovance Biotherapeutics Today @themotleyfool #stocks $IOVA

Theres plenty of upside with this stock, but it might take a while to realize.…

3 Things You Need to Know if You Buy Iovance Biotherapeutics Today

Theres plenty of upside with this stock, but it might take a while to realize.…

Iovance Therapeutics: Historic Product, Tough Commercial Outlook

…

Iovance Biotherapeutics to Present at Upcoming Conferences

SAN CARLOS, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”),…

Up 47% in 2024: Where Will Iovance Biotherapeutics Be in 5 Years? @themotleyfool #stocks $IOVA

This companys new cancer therapy is producing remarkable results, but the company is losing money at a frightening pace.…

Up 47% in 2024: Where Will Iovance Biotherapeutics Be in 5 Years?

This companys new cancer therapy is producing remarkable results, but the company is losing money at a frightening pace.…

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., Aug. 16, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”),…

This 1 Big Risk Is Also 1 Big Opportunity for Iovance Biotherapeutics Stock

It could demonstrate a few capabilities that no other biotech has as of yet.…

Iovance Biotherapeutics, Inc. 2024 Q2 - Results - Earnings Call Presentation

…

Iovance Biotherapeutics Attracted a Downgrade. Is It Time to Sell?

Find out how concerned investors should be about setbacks for this companys revolutionary new cancer therapies.…

Iovance Biotherapeutics Attracted a Downgrade. Is It Time to Sell? @themotleyfool #stocks $IOVA $MRK $PIPR $SF

Find out how concerned investors should be about setbacks for this companys revolutionary new cancer therapies.…

Why Iovance Biotherapeutics Stock Stumbled Today

One pundit warns of apparent manufacturing issues with the companys melanoma drug.…

Iovance Biotherapeutics downgraded to Neutral at Piper Sandler, stock falls

…

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., July 19, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”),…

Is Iovance Biotherapeutics a Millionaire Maker?

This biotechs future is bright, but how good could it get for investors?…

Is It Too Late to Buy Iovance Biotherapeutics Stock? @themotleyfool #stocks $IOVA

The stock is down more than 50% from its 52-week high.…

Is It Too Late to Buy Iovance Biotherapeutics Stock?

The stock is down more than 50% from its 52-week high.…

Iovance Biotherapeutics: Amtagvi Launch Continues Upward

…

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., June 21, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”),…

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”),…

Earnings call: Iovance Biotherapeutics posts Q1 2024 results By Investing.com

Earnings call: Iovance Biotherapeutics posts Q1 2024 results…

Iovance Biotherapeutics, Inc. (IOVA) Q1 2024 Earnings Call Transcript

…

Where Will Iovance Biotherapeutics Stock Be in 5 Years?

Is this rising healthcare stock a good buy right now?…

Where Will Iovance Biotherapeutics Stock Be in 5 Years? @themotleyfool #stocks $IOVA

Is this rising healthcare stock a good buy right now?…

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”),…

Is Iovance Biotherapeutics Stock a Buy Now?

Lets find out if this biotech can keep up its recent momentum.…

Iovance Biotherapeutics: Riding The Favorable Moment Could Bring Excellent Results

…

Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics

These companies are in the early days of their growth stories.…

Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics @themotleyfool #stocks $IOVA $CRSP

These companies are in the early days of their growth stories.…

Iovance Biotherapeutics: Initial Amtagvi Launch In Focus

…

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”),…

Piper Sandler lifts Iovance Biotherapeutics stock target to $19 By Investing.com

Piper Sandler lifts Iovance Biotherapeutics stock target to $19…

Iovance Biotherapeutics Stock Has 22% Upside, According to 1 Wall Street Analyst

With its first approval in hand, attention is now on the top line.…

Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer

SAN CARLOS, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company…

dpa-AFX ProFeed